IVC Filter Guidelines Published by SIR – Allows Physicians Treating Patients at Risk of a PE to Make Evidence-Based Decisions

September 9, 2020

IVC Filter Guidelines: The Society of Interventional Radiology published new clinical practice guidelines that provide evidence-based recommendations on the use of inferior vena cava filters to treat venous thromboembolism (VTE).

“IVC Filter guidelines allow physicians treating patients at risk of a pulmonary embolism to make evidence-based decisions about the use of IVC filters,” said John A. Kaufman, MD, MS, FSIR, the guidelines’ primary author and chair of the department of interventional radiology at Oregon Health & Science University in Portland. “Throughout the process, the multidisciplinary team followed a gold-standard methodology to ensure we reached the best possible consensus on VTE patient care.”

The guidelines advise against the routine placement of inferior vena cava (IVC) filters in most VTE cases where patients are being successfully treated with anticoagulants. However, if anticoagulation therapies fail or are not indicated for the patient, IVC filters may be considered as a treatment option if clinical risk factors such as bleeding, vascular injury, device migration and increased risk of recurrent deep vein thrombosis (DVT) are considered and deemed low.

When IVC filters are placed, the guidelines recommend a follow-up program to increase retrieval and detect complications. In addition, if patients with retrievable IVC filters are no longer at risk of developing a pulmonary embolism, the guidelines recommend removal unless the risk outweighs the benefits.

“With these multidisciplinary guidelines, the authors have removed any inconsistencies and uncertainties older guidelines may have presented physicians treating patients with VTE,” said SIR President Michael D. Dake, MD, FSIR, senior vice president of the University of Arizona Health Sciences in Tucson. “The authors should be proud of this achievement.”

This is SIR’s first official clinical practice guideline, developed using gold-standard guideline methodology following the Standards for Trustworthy Clinical Practice Guidelines set by the National Academy of Medicine. SIR is committed to continuing developing evidence-based clinical practice guidelines to optimize patient care and improve patient outcomes.

The guidelines were developed in collaboration with and endorsed by the American College of Cardiology, the American Heart Association/American Stroke Association, American College of Surgeons (Committee on Trauma), American College of Chest Physicians (CHEST), Society for Vascular Medicine, Society for Vascular Surgery. The Canadian Association for Interventional Radiology and Cardiovascular and Interventional Radiological Society of Europe have also endorsed the guidelines. The American Society of Hematology has affirmed the value of the statement.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.